Literature DB >> 10694331

Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction?

T Clausen1, S Djurovic, F R Brosstad, K Berg, T Henriksen.   

Abstract

OBJECTIVE: The purpose of this study was to investigate whether indications of activation of the maternal endothelium were present at 18 weeks' gestation in women in whom preeclampsia eventually developed. STUDY
DESIGN: A total of 2190 blood samples were obtained at 18 weeks' gestation. Circulating levels of von Willebrand factor and soluble vascular adhesion molecule 1, soluble intercellular adhesion molecule 1, and E-selectin were assayed in 71 women with eventual preeclampsia and 71 control subjects.
RESULTS: E-selectin and von Willebrand factor levels were similar between the 2 groups. Soluble vascular adhesion molecule 1 concentration was significantly lower in the women with eventual preeclampsia (median, 649.0 ng/mL vs 762.4 ng/mL; P <.001), whereas soluble intercellular adhesion molecule 1 concentration was significantly higher (median, 239.8 ng/mL vs 178.3 ng/mL; P <.001).
CONCLUSION: We found no indications of endothelial activation at 18 weeks' gestation in women in whom preeclampsia later developed. However, decreased serum concentration of soluble vascular adhesion molecule 1 and increased serum concentration of soluble intercellular adhesion molecule 1 may reflect the disturbed placentation known to be associated with the development of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694331     DOI: 10.1016/s0002-9378(00)70218-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Diagnostic value of the Conventional and Doppler ultrasound in pregnancy complicated with preeclampsia.

Authors:  M Lubomirova; E Andreev; B Bogov; R Djerassi; B Kiperova; A Nikolov; V Stoykova; V Diavolov; A Dimitrov
Journal:  Hippokratia       Date:  2006-07       Impact factor: 0.471

Review 2.  Association of microparticles and preeclampsia.

Authors:  Fabiana K Marques; Fernanda M F Campos; Lirlândia P Sousa; Andréa Teixeira-Carvalho; Luci M S Dusse; Karina B Gomes
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

3.  Activation of NF-κB in placentas of women with preeclampsia.

Authors:  John E Vaughan; Scott W Walsh
Journal:  Hypertens Pregnancy       Date:  2012-03-01       Impact factor: 2.108

Review 4.  Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia.

Authors:  Mitsuko Furuya; Kentaro Kurasawa; Kiyotaka Nagahama; Kae Kawachi; Akinori Nozawa; Tsuneo Takahashi; Ichiro Aoki
Journal:  J Pregnancy       Date:  2011-03-03

5.  Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study.

Authors:  J Khoury; T Henriksen; I Seljeflot; L Mørkrid; K F Frøslie; S Tonstad
Journal:  BJOG       Date:  2007-03       Impact factor: 6.531

6.  Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study.

Authors:  Mei Du; Arpita Basu; Dongxu Fu; Mingyuan Wu; Michael Centola; Alicia J Jenkins; Kristian F Hanssen; Satish K Garg; Samar M Hammad; James A Scardo; Christopher E Aston; Timothy J Lyons
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112

7.  An Association between Bevacizumab and Recurrent Posterior Reversible Encephalopathy Syndrome in a Patient Presenting with Deep Vein Thrombosis: A Case Report and Review of the Literature.

Authors:  Mark Lazarus; Stanley Amundson; Rajesh Belani
Journal:  Case Rep Oncol Med       Date:  2012-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.